Asthma Market Research Reports

Asthma Market Research

There are many reasons behind the increasing incidences of Asthma today. The key factors causing prevalence of asthma in the ... view more

RSS Sort By :
TITLE Price Buy Now More options

GlobalData has released its new PharmaPoint Drug Evaluation report, “Xolair (Asthma) Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficac...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Benralizumab (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively e...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Singulair (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effi...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with re...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, “Symbicort (Asthma) Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effi...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively e...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Fostair (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effica...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, “Flovent (Asthma) Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effica...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, “Breo Ellipta (Asthma) Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively e...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Flutiform (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effi...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Fluticasone Furoate (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relat...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with rela...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, “Spiriva (Asthma) Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effica...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, “Pulmicort (Asthma) Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effi...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Dulera (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficac...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, “Advair (Asthma) Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficac...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Dupilumab (Asthma) - Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effi...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Quilizumab (Asthma) Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively effic...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Tralokinumab (Asthma) Forecast and Market Analysis to 2023". The asthma market saw very slow growth over the past decade, as it has become saturated with relatively eff...

$ 3495


GlobalData has released its pharma report, "PharmaPoint: Asthma Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Asthma Market. The report ...

$ 2995

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: